SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-006734
Filing Date
2019-02-04
Accepted
2019-02-04 15:51:03
Documents
2
Period of Report
2019-01-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3087
2 POA DOCUMENT poa.txt EX-24.3_829709 3997
  Complete submission text file 0001209191-19-006734.txt   8783
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Issuer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3300 SOUTH DIXIE HIGHWAY, SUITE 1-365 WEST PALM BEACH FL 33405
Business Address 3300 SOUTH DIXIE HIGHWAY, SUITE 1-365 WEST PALM BEACH FL 33405 (858) 829-6713
Alimco Financial Corp (Reporting) CIK: 0001763340 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-21214 | Film No.: 19563586